Utilities and other high yielding sectors are reaching overbought levels, so investors may want to rotate into biotechs, says TheStreet's Jim Cramer. Cramer said packaged-goods companies and REITs have reached their 'outer-limits' and the money in those areas may gravitate to biotech stocks that have been pressured in the past year. Cramer highlighted a bullish call by RealMoney technical strategist Bruce Kamich on Regeneron (REGN) , saying the stock is poised for a major breakout. Regeneron reports quarterly earnings on Thursday before the open.
More from Video
Is Renewable Energy the Defensive Stock Opportunity You're Missing
AMSC CEO discusses that and China challenges.
Takeda Pharmaceutical CEO Talks Big Pharma Trends
One of pharma's biggest CEO's talks M&A action on the exchange.
Real Money Video Wrap: Citi Surges as View of Stability Saves Sentiment
Citi overcame a mixed print to send its stock surging on Monday.
Real Money Video Wrap: Apple Rallies as Services Segment Takes Center Stage
There is a lot of Apple news to chew on Wednesday.
Are Algos Jumping on J&J Headlines?
Are machines jumping on Johnson & Johnson's human risk headlines?
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.